International Journal of Clinical Obstetrics and Gynaecology

To meet the need to control the growing population of developing countries like India, the introduction of various permanent and temporary family planning methods has presented ample options. The long-acting injectable progestogens such as D.M.P.A are highly effective, safe, long-acting and user-friendly contraception, proving to be a flexible option for women, for whom estrogen-containing contraceptives are medically contraindicated.
Objectives: To evaluate the acceptance of D.M.P. A. Among the tribal women visiting the tertiary care centre in eastern India.
Methodology: This prospective observational study was conducted at the department of Obstetrics/Gynaecology of M.G.M Medical College and Hospital, Jamshedpur, over the period of June 2022 to October 2023. 109 tribal women participated in the study, were followed up on every 3months, and an assessment was done using questionnaires during their follow-up.
Results: Out of 109 tribal women, 31 women belonged to a group of 28 y-31 yrs., 33 women had primary educations. 73 women were from rural areas, 63 women were para 2, and the majority of patients chose to have it after 6 weeks of delivery. 62 patients continued to follow up for 3 months, while 43 patients discontinued. The most common reason for acceptance of DMPA was that there was no monthly bleeding, while 19 women discontinued due to its side effects, such as spotting, and 14 women lost their follow-up.
Conclusion: Promotion of use of injectable contraceptives should be done through social marketing, campaigns by health workers and family planning camps by circulating proper information, especially in rural areas among tribal communities.